LS ARK Genomic Revolution Tracker ETP Securities
|
|
ISIN: XS2399368062
Nettoinventarwert (NAV)
| 2,29 USD | -0,03 USD | -1,17 % |
|---|
| Vortag | 2,31 USD | Datum | 07.11.2025 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
LS ARK Genomic Revolution Tracker ETP Securities aktueller Kurs
| 1,98 EUR | -0,02 EUR | -1,00 % |
|---|
| Datum | 11.11.2025 14:57:19 |
| Vortag | 2,00 EUR |
| Börse | Düsseldorf |
Rating für LS ARK Genomic Revolution Tracker ETP Securities
| €uro FondsNote | - |
Fonds Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 7,81 | |
| Performance 2 Jahre | 15,99 | |
| Performance 3 Jahre | -10,01 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |
Fundamentaldaten
| WKN | |
| ISIN | XS2399368062 |
| Name | LS ARK Genomic Revolution Tracker ETP Securities |
| Fondsgesellschaft | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 952 675,33 |
| Depotbank | |
| Zahlstelle | |
| Fondsmanager | |
| Geschäftsjahresende | |
| Berichtsstand | 10.11.2025 |
Konditionen
| Ausgabeaufschlag | % |
| Verwaltungsgebühr | % |
| Depotbankgebühr | % |
| VL-fähig? | Nein |
| Mindestanlage | |
| Ausschüttung | Thesaurierend |